Please assess the completion status of the following clinical trial:

Trial Title: Malaria Diagnostic Testing and Conditional Subsidies to Target ACTs in the Retail Sector: the TESTsmART Trial AIM 1

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: FACTORIAL
- Observational Model: None
- Primary Purpose: HEALTH_SERVICES_RESEARCH
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 4.0

Eligibility Criteria:
Inclusion Criteria:~* Participants with fever or history of fever or malaria like illness~* Individual with malaria-like illness must be present at recruitment~* 1 year of age or older~Exclusion Criteria:~* Any individual with signs of severe illness requiring immediate referral~* Individuals who have taken an antimalarial in the last seven days, including for the current illness~* Individuals who already have a prescription from a facility or medical provider~* Pregnant women will be enrolled and offered an mRDT, but will be advised to seek treatment through a health care provider.

- Gender: ALL
- Minimum Age: 1 Year
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Arm 1 (Type: EXPERIMENTAL): The subsidy levels for participants randomly assigned to Arm 1 are: No subsidy for RDT (price to consumer=$0.40); 100% ACT subsidy (price to consumer=0).
- Arm 2 (Type: EXPERIMENTAL): The subsidy levels for participants randomly assigned to Arm 2 are: No subsidy for RDT (price to consumer=$0.40); 67% ACT subsidy (price to consumer=$0.10-0.40, dependent upon patient age).
- Arm 3 (Type: EXPERIMENTAL): The subsidy levels for participants randomly assigned to Arm 3 are: 50% subsidy for RDT (price to consumer=$0.20); 100% ACT subsidy (price to consumer=0).
- Arm 4 (Type: EXPERIMENTAL): The subsidy levels for participants randomly assigned to Arm 4 are: 50% subsidy for RDT (price to consumer=$0.20); 67% ACT subsidy (price to consumer=$0.10-0.40, dependent upon patient age)

Based on this trial design, predict the completion outcome and termination type (if applicable).